Biocom California, the association representing the California life science industry, today announced the winners of its 10th annual Life Science Catalyst Awards. The awards recognize rising and ...
Hosted on MSN
12 Life Stories That Stay With You
Today, I’m breaking down the top 12 biographies you MUST read before you die. Hegseth announces another US attack on alleged drug boat off Venezuelan coast House Republican on mass firings: ‘We have a ...
Welcome to the second edition of our newsletter. The response to our inaugural issue reinforced what we already knew to be true: the life sciences community thrives on active dialogue. As we move ...
“Wildlife Science Education for Grades 3-12” guides and encourages youth to learn about the wildlife around them. The first section introduces the basic wildlife groups to youth in upper elementary ...
India has become a global hub for pharmaceutical and life sciences global capability centres (GCCs), attracting top companies in recent years. Supported by a large talent pool, India has evolved into ...
180 Life Sciences Corp (NASDAQ:ATNF) shares are soaring Tuesday after the company provided an update on its Ethereum (CRYPTO: ETH) treasury strategy. What Happened: At the end of July, 180 Life ...
Frazier Life Sciences has gathered an impressive $1.3 billion in capital commitments for its 12th venture fund aimed at private early-stage biotechs. The Palo Alto-based firm said it has now raised ...
June 17 (Reuters) - Caris Life Sciences raised $494.1 million in its Nasdaq initial public offering, the cancer diagnostic firm said on Tuesday, amid a rebound in the IPO market. Investors have shown ...
The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion. Caris Life Sciences, a cancer diagnostics company based in Irving, Texas, uses gene ...
Caris Life Sciences CEO and chairman David Dean Halbert, celebrates the company's initial public offering and listing on the Nasdaq exchange by ringing the opening bell on Wednesday, June 18, 2025.
SELLAS Life Sciences' value hinges on the pivotal REGAL phase 3 trial in AML, with interim results showing promise, but final outcomes still unknown. Despite encouraging data, I remain highly cautious ...
May 23 (Reuters) - Biotech company Caris Life Sciences filed its paperwork to go public in the U.S. on Friday as the stock market shows signs of recovery after tariff shocks. Irving, Texas-based firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback